Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system.

Mostafa EnayatradSepideh MahdaviRoqayeh AliyariSajad Sahab-NegahSairan NiliMohammad FereidouniParvin Mangolian ShahrbabakiAlireza Ansari-MoghaddamAbtin HeidarzadehFariba Shahraki-SanaviMansooreh FatehHamidreza KhajehaZahra EmamianElahe BehmaneshHossein SheibaniMaryam AbbaszadehReza JafariMaryam ValikhaniEhsan BineshHamid VahediReza ChamanHamid SharifiMohammad Hassan Emamian

Published in: BMC infectious diseases (2023)

Pain and fatigue were the most common reactogenicities of COVID-19 vaccination. Reactogenicities were less common after the second dose of the vaccines. The adverse effects of AZD1222 were greater than those of other vaccines.

Keyphrases

coronavirus disease
sars cov
chronic pain
public health
pain management
neuropathic pain
sleep quality
spinal cord
spinal cord injury
placebo controlled
drug induced
double blind